Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Kathryn Ann Martin, M.D.

Co-Author

This page shows the publications co-authored by Kathryn Martin and William Crowley.
Connection Strength

0.835
  1. Comparison of exogenous gonadotropins and pulsatile gonadotropin-releasing hormone for induction of ovulation in hypogonadotropic amenorrhea. J Clin Endocrinol Metab. 1993 Jul; 77(1):125-9.
    View in: PubMed
    Score: 0.136
  2. Clinical review 15: Management of ovulatory disorders with pulsatile gonadotropin-releasing hormone. J Clin Endocrinol Metab. 1990 Nov; 71(5):1081A-1081G.
    View in: PubMed
    Score: 0.113
  3. The Reproductive Endocrine Associates of the Massachusetts General Hospital: fifteen years of integrated clinical practice and investigation. J Clin Endocrinol Metab. 1999 Jun; 84(6):1912-8.
    View in: PubMed
    Score: 0.051
  4. Is GnRH reduced at the midcycle surge in the human? Evidence from a GnRH-deficient model. Neuroendocrinology. 1998 Jun; 67(6):363-9.
    View in: PubMed
    Score: 0.048
  5. A randomized, controlled trial of estradiol replacement therapy in women with hypergonadotropic amenorrhea. J Clin Endocrinol Metab. 1996 Oct; 81(10):3615-21.
    View in: PubMed
    Score: 0.043
  6. Midcycle levels of sex steroids are sufficient to recreate the follicle-stimulating hormone but not the luteinizing hormone midcycle surge: evidence for the contribution of other ovarian factors to the surge in normal women. J Clin Endocrinol Metab. 1995 May; 80(5):1541-7.
    View in: PubMed
    Score: 0.039
  7. Potential for fertility with replacement of hypothalamic gonadotropin-releasing hormone in long term female survivors of cranial tumors. J Clin Endocrinol Metab. 1994 Oct; 79(4):1166-72.
    View in: PubMed
    Score: 0.037
  8. Decreased release of gonadotropin-releasing hormone during the preovulatory midcycle luteinizing hormone surge in normal women. Proc Natl Acad Sci U S A. 1994 Jul 19; 91(15):6894-8.
    View in: PubMed
    Score: 0.036
  9. New approaches to the study of the neuroendocrine abnormalities of women with the polycystic ovarian syndrome. Ann N Y Acad Sci. 1993 May 28; 687:182-92.
    View in: PubMed
    Score: 0.034
  10. An overview of the diagnostic considerations in polycystic ovarian syndrome. Ann N Y Acad Sci. 1993 May 28; 687:235-41.
    View in: PubMed
    Score: 0.034
  11. Responsiveness to a physiological regimen of GnRH therapy and relation to genotype in women with isolated hypogonadotropic hypogonadism. J Clin Endocrinol Metab. 2013 Feb; 98(2):E206-16.
    View in: PubMed
    Score: 0.033
  12. Hypothalamic gonadotropin-releasing hormone secretion and follicle-stimulating hormone dynamics during the luteal-follicular transition. J Clin Endocrinol Metab. 1992 Mar; 74(3):600-7.
    View in: PubMed
    Score: 0.031
  13. Precursors of alpha-inhibin modulate follicle-stimulating hormone receptor binding and biological activity. Endocrinology. 1991 Oct; 129(4):1987-99.
    View in: PubMed
    Score: 0.030
  14. A genetic basis for functional hypothalamic amenorrhea. N Engl J Med. 2011 Jan 20; 364(3):215-25.
    View in: PubMed
    Score: 0.029
  15. Expanding the phenotype and genotype of female GnRH deficiency. J Clin Endocrinol Metab. 2011 Mar; 96(3):E566-76.
    View in: PubMed
    Score: 0.029
  16. Closed intravenous administration of gonadotropin-releasing hormone: safety of extended peripheral intravenous catheterization. Obstet Gynecol. 1989 Aug; 74(2):267-70.
    View in: PubMed
    Score: 0.026
  17. GNRHR mutations in a woman with idiopathic hypogonadotropic hypogonadism highlight the differential sensitivity of luteinizing hormone and follicle-stimulating hormone to gonadotropin-releasing hormone. J Clin Endocrinol Metab. 2004 Jul; 89(7):3189-98.
    View in: PubMed
    Score: 0.018
  18. Prevalence, phenotypic spectrum, and modes of inheritance of gonadotropin-releasing hormone receptor mutations in idiopathic hypogonadotropic hypogonadism. J Clin Endocrinol Metab. 2001 Apr; 86(4):1580-8.
    View in: PubMed
    Score: 0.015
  19. Successful use of pulsatile gonadotropin-releasing hormone (GnRH) for ovulation induction and pregnancy in a patient with GnRH receptor mutations. J Clin Endocrinol Metab. 2000 Feb; 85(2):556-62.
    View in: PubMed
    Score: 0.013
  20. Exaggerated free alpha-subunit levels during pulsatile gonadotropin-releasing hormone replacement in women with idiopathic hypogonadotropic hypogonadism. J Clin Endocrinol Metab. 1998 Jan; 83(1):241-7.
    View in: PubMed
    Score: 0.012
  21. Frequency modulation of follicle-stimulating hormone (FSH) during the luteal-follicular transition: evidence for FSH control of inhibin B in normal women. J Clin Endocrinol Metab. 1997 Aug; 82(8):2645-52.
    View in: PubMed
    Score: 0.011
  22. Homologous in vitro bioassay for follicle-stimulating hormone (FSH) reveals increased FSH biological signal during the mid- to late luteal phase of the human menstrual cycle. J Clin Endocrinol Metab. 1996 Jun; 81(6):2080-8.
    View in: PubMed
    Score: 0.010
  23. Relatively low levels of dimeric inhibin circulate in men and women with polycystic ovarian syndrome using a specific two-site enzyme-linked immunosorbent assay. J Clin Endocrinol Metab. 1994 Jul; 79(1):45-50.
    View in: PubMed
    Score: 0.009
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.